Table 3.
Dataset | Method | Thresholds | Selection | Runtime (s) | Error |
---|---|---|---|---|---|
DLBCL |
FCROS |
0.0228, 0.9773 |
424 |
4.79 |
4.55% |
(n = 7129) |
FC |
1.444 |
425 |
0.13 |
na |
(m1 = 58, m2 = 19) |
WAD |
1.1575 |
424 |
0.14 |
na |
|
RP |
0 |
425 |
656.36 |
0% |
|
Ttest |
0.0001 |
428 |
1.48 |
0.17% |
|
SAM |
0.00032 |
427 |
26.66 |
0.5% |
|
TREAT |
0.0025 |
425 |
0.16 |
4.19% |
Prostate |
FCROS |
0.0356, 0.9644 |
1009 |
19.58 |
7.12% |
(n = 12625) |
FC |
1.27 |
1008 |
0.3 |
na |
(m1 = 50, m2 = 52) |
WAD |
1.0805 |
1010 |
0.32 |
na |
|
RP |
0 |
1010 |
2491.54 |
0% |
|
Ttest |
0.00068 |
1008 |
2.72 |
0.85% |
|
SAM |
0.00041 |
1013 |
55.6 |
0.51% |
|
TREAT |
0.0153 |
1010 |
0.33 |
19.12% |
Colon |
FCROS |
0.0187, 0.9802 |
95 |
0.99 |
3.85% |
(n = 2000) |
FC |
1.8 |
95 |
0.05 |
na |
(m1 = 22, m2 = 40) |
WAD |
1.346 |
95 |
0.08 |
na |
|
RP |
0 |
96 |
168.78 |
0% |
|
Ttest |
0.00015 |
97 |
0.5 |
0.3% |
|
SAM |
0.00055 |
95 |
7.08 |
1.15% |
|
TREAT |
0.00028 |
95 |
0.06 |
0.58% |
Leukemia |
FCROS |
0.028, 0.9717 |
493 |
4.7 |
5.63% |
(n = 7129) |
FC |
1.942 |
494 |
0.12 |
na |
(m1 = 47, m2 = 25) |
WAD |
1.1668 |
494 |
0.17 |
na |
|
RP |
0 |
494 |
768.65 |
0% |
|
Ttest |
0.00052 |
494 |
1.43 |
0.75% |
|
SAM |
0.00051 |
494 |
28.71 |
0.74% |
|
TREAT |
0.00153 |
494 |
0.13 |
2.2% |
Myeloma |
FCROS |
0.01296, 0.987 |
450 |
34.77 |
2.59% |
(n = 12625) |
FC |
1.5189 |
452 |
0.4 |
na |
(m1 = 36, m2 = 137) |
WAD |
1.212 |
449 |
0.49 |
na |
|
RP |
0 |
451 |
4721.73 |
0% |
|
Ttest |
0.0051 |
449 |
2.9 |
14.34% |
|
SAM |
0.0055 |
450 |
94.84 |
15.43% |
|
TREAT |
0.0192 |
451 |
0.54 |
53.75% |
ALL-1 |
FCROS |
0.0355, 0.9644 |
1187 |
22.72 |
7.11% |
(n = 12625) |
FC |
1.4176 |
1187 |
0.5 |
na |
(m1 = 95, m2 = 33) |
WAD |
1.1165 |
1185 |
0.64 |
na |
|
RP |
0 |
1188 |
3108.43 |
0% |
|
Ttest |
0.000057 |
1186 |
2.66 |
0.06% |
|
SAM |
0.000145 |
1187 |
69.48 |
0.15% |
TREAT | 0.00117 | 1184 | 0.26 | 1.25% |
Comparative results for six microarray datasets (na = not available).